Last CNY14.96 CNY
Change Today +0.05 / 0.34%
Volume 29.4M
601607 On Other Exchanges
Symbol
Exchange
Shanghai
Berlin
OTC US
OTC US
Hong Kong
As of 2:05 AM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitleKey Developments
Naiwei Chen 22 RelationshipsIndependent Non-Executive Director, Convener of Remuneration & Assessment Committee, Member of Audit Committee and Member of Nomination Committee 
Cho Che Tse 8 RelationshipsIndependent Non-Executive Director, Convener of Nomination Committee, Member of Strategy Committee and Member of Audit Committee 
Kam To Wan 77 RelationshipsIndependent Non-Executive Director, Convener of Audit Committee and Member of Remuneration & Assessment Committee 

Compensation Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitle
Naiwei Chen 22 RelationshipsIndependent Non-Executive Director, Convener of Remuneration & Assessment Committee, Member of Audit Committee and Member of Nomination Committee
Zhenfu Li 8 RelationshipsIndependent Non-Executive Director, Member of Remuneration & Assessment Committee and Member of Strategy Committee
Kam To Wan 77 RelationshipsIndependent Non-Executive Director, Convener of Audit Committee and Member of Remuneration & Assessment Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for 601607.
52 Week Price Performance
Share price activity for SHANGHAI PHARMACEUTICALS-A (601607)
601607
Industry Average

Nominating Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitleKey Developments
Dingbo Lou 28 RelationshipsChairman, Convener of Strategy Committee and Member of Nomination CommitteeShanghai Pharmaceuticals Holding Co., Ltd. Approves the Appointment of Hu Fengxiang to the Board of Directors; Approves Dividend for Year 2012, Payable on or Around July 30, 2013
06/5/13
Naiwei Chen 22 RelationshipsIndependent Non-Executive Director, Convener of Remuneration & Assessment Committee, Member of Audit Committee and Member of Nomination CommitteeShanghai Pharmaceuticals Holding Co., Ltd. Announces Board Changes
06/5/13
Cho Che Tse 8 RelationshipsIndependent Non-Executive Director, Convener of Nomination Committee, Member of Strategy Committee and Member of Audit CommitteeShanghai Pharmaceutical Co., Ltd. Announces Executive Changes; Declares Dividend for the Year 2011; Announces Amendments to its Articles of Association
05/31/12
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY14.96 CNY +0.05

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY51.95 CNY -1.05
Jointown Pharmaceutical Group Co Ltd CNY16.84 CNY +0.37
Nanjing Pharmaceutical Co Ltd CNY8.19 CNY +0.04
Wanjia Group Holdings Ltd $0.52 HKD -0.06
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 16.1x
Price/Sales 0.5x
Price/Book 1.5x
Price/Cash Flow 11.5x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.